Low concentration meloxicam tablets

US10278924B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

• Martin A. Folger · Ingelheim am Rhein, DE
• Stefan Lehner · Wiesbaden, DE
• Horst Schmitt · Nieder-Hilbersheim, DE

Key dates

• Filing date: Sep 11, 2017
• Grant date: May 7, 2019
• Expiry date: Sep 11, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/5415
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described herein is a solid tablet that is directly-compressed of powder, including meloxicam and one or more excipients which are homogenously dispersed within the tablet that can be broken into two, three or four units with each unit containing equal amounts of the active ingredient, meloxicam.